Abstract:Background The metabolic syndrome (MetS) epidemic is associated with economic development, lifestyle transition and dysbiosis of gut microbiota, but these associations are rarely studied at the population scale. Here, we utilised the Guangdong Gut Microbiome Project (GGMP), the largest Eastern population-based gut microbiome dataset covering individuals with different economic statuses, to investigate the relationships between the gut microbiome and host physiology, diet, geography, physical activity and socioeconomic status. Results At the population level, 529 OTUs were significantly associated with MetS. OTUs from Proteobacteria and Firmicutes (other than Ruminococcaceae) were mainly positively associated with MetS, whereas those from Bacteroidetes and Ruminococcaceae were negatively associated with MetS. Two hundred fourteen OTUs were significantly associated with host economic status (140 positive and 74 negative associations), and 157 of these OTUs were also MetS associated. A microbial MetS index was formulated to represent the overall gut dysbiosis of MetS. The values of this index were significantly higher in MetS subjects regardless of their economic status or geographical location. The index values did not increase with increasing personal economic status, although the prevalence of MetS was significantly higher in people of higher economic status. With increased economic status, the study population tended to consume more fruits and vegetables and fewer grains, whereas meat consumption was unchanged. Sedentary time was significantly and positively associated with higher economic status. The MetS index showed an additive effect with sedentary lifestyle, as the prevalence of MetS in individuals with high MetS index values and unhealthy lifestyles was significantly higher than that in the rest of the population. Conclusions The gut microbiome is associated with MetS and economic status. A prolonged sedentary lifestyle, rather than Westernised dietary patterns, was the most notable lifestyle change in our Eastern population along with economic development. Moreover, gut dysbiosis and a Western lifestyle had an additive effect on increasing MetS prevalence.

Symbiotic gut microbes modulate human metabolic phenotypes

Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis

Interplay between the human gut microbiome and host metabolism

Integration of gut microbiome, host biomarkers, and urine metabolome data reveals networks of interactions associated with distinct clinical phenotypes

The footprints of gut microbial-mammalian co-metabolism.

Multi-Omic Analysis of the Microbiome and Metabolome in Healthy Subjects Reveals Microbiome-Dependent Relationships Between Diet and Metabolites

Strain-level Dissection of the Contribution of the Gut Microbiome to Human Metabolic Disease

Genomic diversity and underlying metabolic variations of the human gut microbiome between populations at single nucleotide resolution

FROM MICROBIOME TO METABOLOME

Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals

Diets, Gut Microbiota and Metabolites

Metabolite interactions between host and microbiota during health and disease: Which feeds the other?

Microbial-Host Co-metabolites Are Prodromal Markers Predicting Phenotypic Heterogeneity in Behavior, Obesity, and Impaired Glucose Tolerance

Population-based metaproteomics reveals functional associations between gut microbiota and phenotypes

Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.

Mapping human microbiome drug metabolism by gut bacteria and their genes

Gut Microbiota Has a Widespread and Modifiable Effect on Host Gene Regulation

Therapeutic modulation of microbiota-host metabolic interactions.

Gut microbiota-generated metabolites: missing puzzles to hosts' health, diseases, and aging

Gut microbial genomes with paired isolates from China illustrate probiotic and cardiometabolic effects

Not just a gut feeling: a deep exploration of functional bacterial metabolites that can modulate host health